{
  "docId": "019de073-3cb6-7521-8cc2-fe64231d84c9",
  "docSlug": "d538949ee3add2afed287b359e626655",
  "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 25 slides",
  "authorId": "an2-therapeutics",
  "authorName": "AN2 Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 22,
  "pageCount": 25,
  "prevPage": 21,
  "nextPage": 23,
  "slideType": "use_of_funds",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 1,
  "notes": "The timeline shows clinical trial phases (Chronic Tox, Phase 1b, Ph 2/3 TR-MAC, Ph 1 Japan, Ph 2/3 Topline Data).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-3cb6-7521-8cc2-fe64231d84c9/22",
  "deckHref": "/decks/019de073-3cb6-7521-8cc2-fe64231d84c9",
  "deckJsonHref": "/decks/019de073-3cb6-7521-8cc2-fe64231d84c9.json",
  "deckAnchorHref": "/decks/019de073-3cb6-7521-8cc2-fe64231d84c9#slide-22",
  "components": [
    {
      "bbox": {
        "h": 0.18,
        "w": 0.68,
        "x": 0.28,
        "y": 0.4
      },
      "kind": "chart",
      "text": "Clinical trial timeline from 2021 to 2024",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bf0e9b89-1928-4efc-a8c8-f4b7d432169c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.6,
        "x": 0.28,
        "y": 0.11
      },
      "kind": "list",
      "text": "$115.8 cash, cash equivalents and investments as of 6/30/2022\nExpect to be sufficient to fund operating expenses through mid-2024",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "176bbdaa-b813-4f5a-9d5c-bbeea49289a2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.24,
        "x": 0.02,
        "y": 0.07
      },
      "kind": "title",
      "text": "Existing cash funds value driving milestones",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4eaa4576-587f-4c96-b0d8-a55760dd69be",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Waterfall chart",
      "slug": "waterfall-chart",
      "agent": null,
      "layer": "slide",
      "matchId": "4a060af3-898d-49bc-b20a-cd2a3c7d43ae",
      "evidence": "chart/timeline: Clinical trial timeline from 2021 to 2024",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "748ed387-ce5e-41d3-a4e9-9c1818b61eb8",
      "evidence": "The slide uses a horizontal timeline to map clinical milestones against calendar years.",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 22,
      "from": 19,
      "beatId": "397f2f22-31e1-4ec6-8a66-a5d5f79bbcd3",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Business Model",
      "beatSlug": "sequoia-pitch-business-model",
      "evidence": "Slides 19-22 present the business model, including market opportunity, target product profile, and intellectual property",
      "position": 3,
      "confidence": 0.9,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}